IMCB extends a warm welcome to Professor Stephen Cohen who joins IMCB from July 1, 2010 as the Deputy Director for Strategic Planning.
Professor Cohen received his Ph.D. from Princeton University, and undertook post-doctoral work at the Whitehead Institute at MIT and later at the Max Planck Institute in Tübigen, Germany, where he began to work on Drosophila developmental genetics. He was a Howard Hughes Medical Institute Assistant Investigator at Baylor College of Medicine in Houston, Texas, before moving to the European Molecular Biology Laboratory in 1993. In 1996, he was appointed the Head of the Developmental Biology Unit and was elected a member of the European Molecular Biology Organization. In 2007, he moved to Singapore to take up a position as the Chief Executive Officer of Temasek Life Sciences Laboratory and, in 2008, he was elected Fellow of the Royal Society of London.
Professor Cohenís research interests have included appendage development and pattern formation, morphogen gradients, growth control and metabolism. For several years, the Cohen laboratory has focused on understanding the biological functions of microRNAs, showing that microRNAs are key regulators of tissue growth, cell death, metabolism and a range of biological processes relevant to development and disease. Their laboratory combines genetic analysis with the development of computational and biochemical tools to understand the biological process affected by microRNA, and to help identify the target genes that microRNAs regulate.
We welcome Professor Cohen and his laboratory to IMCB.
For more information on Stephen Cohenís laboratory, please click here.